[Vertigo and dizziness related to platelet aggregability]

Area of Science:

• Neurology
• Hematology

Context:

• Vertigo and dizziness are common symptoms with various underlying causes.
• Cervical vertigo, characterized by headache, is considered a distinct entity.

Purpose:

• To investigate the role of platelet aggregation in patients experiencing vertigo and dizziness.
• To evaluate the efficacy of platelet aggregation inhibitors in managing these symptoms.

Summary:

• Patients with vertigo and dizziness exhibited significantly increased platelet aggregation compared to controls.
• Treatment with platelet aggregation inhibitors (e.g., ticlopidine) led to symptom resolution and normalization of platelet aggregation.
• Chronological monitoring of platelet aggregation guided medication dosage and demonstrated the importance of sustained therapeutic levels.

Impact:

• This study suggests that elevated platelet aggregation is a significant factor in many cases of vertigo and dizziness.
• It highlights the therapeutic potential of platelet aggregation inhibitors and the necessity of personalized, monitored treatment strategies.